These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9440401)

  • 1. Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.
    Kinnunen E; Junttila O; Haukka J; Hovi T
    Am J Epidemiol; 1998 Jan; 147(1):69-73. PubMed ID: 9440401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign.
    Kinnunen E; Färkkilä M; Hovi T; Juntunen J; Weckström P
    Neurology; 1989 Aug; 39(8):1034-6. PubMed ID: 2788248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.
    Rantala H; Cherry JD; Shields WD; Uhari M
    J Pediatr; 1994 Feb; 124(2):220-3. PubMed ID: 8301426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between oral poliovaccine and Guillain-Barré syndrome?
    Salisbury DM
    Lancet; 1998 Jan; 351(9096):79-80. PubMed ID: 9439487
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barré syndrome.
    Friedrich F; Filippis AM; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):55-8. PubMed ID: 8762640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of five children with Guillain-Barré syndrome following a nationwide oral polio vaccine campaign in Turkey.
    Anlar O; Tombul T; Arslan S; Akdeniz H; Caksen H; Gundem A; Akbayram S
    Neurol India; 2003 Dec; 51(4):544-5. PubMed ID: 14742945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign.
    Uhari M; Rantala H; Niemelä M
    Lancet; 1989 Aug; 2(8660):440-1. PubMed ID: 2569613
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety aspects of oral poliovirus vaccine campaigns.
    Hovi T
    Dev Biol Stand; 1995; 84():137-44. PubMed ID: 7796946
    [No Abstract]   [Full Text] [Related]  

  • 9. Rare adverse events associated with oral poliovirus vaccine in Brazil.
    Friedrich F
    Braz J Med Biol Res; 1997 Jun; 30(6):695-703. PubMed ID: 9292105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barré syndrome in Kuwait: is it related to the oral polio vaccine?
    Ismail EA; Shabani IS; Badawi M; Sanaa H; Madi S; Al-Tawari A; Nadi H; Zaki M; Al-saleh Q
    J Child Neurol; 1998 Oct; 13(10):488-92. PubMed ID: 9796754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality Assessment of Serious Neurologic Adverse Events Following bOPV National Vaccination Campaign in Israel.
    Tasher D; Kopel E; Anis E; Grossman Z; Somekh E
    Isr Med Assoc J; 2016 Oct; 18(10):590-593. PubMed ID: 28471617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.
    Hovi T; Cantell K; Huovilainen A; Kinnunen E; Kuronen T; Lapinleimu K; Pöyry T; Roivainen M; Salama N; Stenvik M
    Lancet; 1986 Jun; 1(8495):1427-32. PubMed ID: 2872526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland.
    Pöyry T; Stenvik M; Hovi T
    Appl Environ Microbiol; 1988 Feb; 54(2):371-4. PubMed ID: 2833160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome in south-west Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence.
    Jiang GX; de Pedro-Cuesta J; Fredrikson S
    Acta Neurol Scand; 1995 Feb; 91(2):109-17. PubMed ID: 7785420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome and the 1978-1979 influenza vaccine.
    Hurwitz ES; Schonberger LB; Nelson DB; Holman RC
    N Engl J Med; 1981 Jun; 304(26):1557-61. PubMed ID: 7231501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain Barré syndrome in a population less than 15 years old in Brazil.
    Dias-Tosta E; Kückelhaus CS
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):367-73. PubMed ID: 12131933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of Guillain-Barré syndrome in southern Finland.
    Färkkilä M; Kinnunen E; Weckström P
    Neuroepidemiology; 1991; 10(5-6):236-41. PubMed ID: 1798424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles vaccination and Guillain-Barré syndrome.
    da Silveira CM; Salisbury DM; de Quadros CA
    Lancet; 1997 Jan; 349(9044):14-6. PubMed ID: 8988116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.